Royal London Asset Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.98M | Sell |
|
|||||
|
2025
Q1 | $4.54M | Sell |
|
|||||
|
2024
Q4 | $6.68M | Sell |
|
|||||
|
2024
Q3 | $22.7M | Buy |
|
|||||
|
2024
Q2 | $39.8M | Sell |
|
|||||
|
2024
Q1 | $41.2M | Buy |
|
|||||
|
2023
Q4 | $36.6M | Buy |
|
|||||
|
2023
Q3 | $37.1M | Sell |
|
|||||
|
2023
Q2 | $47.5M | Sell |
|
|||||
|
2023
Q1 | $63M | Buy |
|
|||||
|
2022
Q4 | $47.1M | Buy |
|
|||||
|
2022
Q3 | $23.4M | Buy |
|
|||||
|
2022
Q2 | $25.2M | Buy |
|
|||||
|
2022
Q1 | $30.3M | Buy |
|
|||||
|
2021
Q4 | $43.3M | Buy |
|
|||||
|
2021
Q3 | $46.1M | Sell |
|
|||||
|
2021
Q2 | $28.6M | Buy |
|
|||||
|
2021
Q1 | $14M | Buy |
|
|||||
|
2020
Q4 | $10.9M | Sell |
|
|||||
|
2020
Q3 | $7.56M | Buy |
|